2022 Taiwan expert consensus and recommendations for thyroid radiofrequency ablation
Wei-Che Lin1 , Wen-Chieh Chen2, Pei-Wen Wang2, Yi-Chia Chan3, Yen-Hsiang Chang4, Harn-Shen Chen5,6, Szu-Tah Chen7, Wei-Chih Chen8, Kai-Lun Cheng9, Shun-Yu Chi3, Pi-Ling Chiang1, Chen-Kai Chou2, Feng-Fu Chou3, Shun-Chen Huang10, Feng-Hsuan Liu7, Sheng-Dean Luo8, Fen-Yu Tseng11,12, Chih-Yuan Wang13, Wen-Hung Wang14, Ming-Hsun Wu15
1Department of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
2Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
3Division of General Surgery and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
4Department of Nuclear Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
5Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan
6Section of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
7Division of Endocrinology and Metabolism, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan
8Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
9Department of Medical Imaging, Chung Shan Medical University Hospital, School of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan
10Department of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
11Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
12Division of Endocrinology and Metabolism, Department of Internal Medicine, Taitung Christian Hospital, Taitung, Taiwan
13Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan
14Department of Otolaryngology, Cathay General Hospital, Taipei City, Taiwan; Department of Otolaryngology, Sijhih Cathay General Hospital, New Taipei City, Taiwan; School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan
15Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
Corresponding Author: Wei-Che Lin ,Tel: +886-7-731-7123 ext , Fax: +886-7-731-7123 ext , Email: alex@cgmh.org.tw
Received: July 29, 2022;  Accepted: November 19, 2022.  Published online: November 19, 2022.
ABSTRACT
Radiofrequency ablation (RFA) is a minimally invasive management strategy which has been widely applied on thyroid benign and recurrent malignant lesions as an alternative to surgery in Taiwan. Experts from the academies associated with interventional radiology, endocrinology, and endocrine surgeons collaborated to develop the first consensus regarding thyroid RFA in Taiwan. The modified Delphi method was used to reach a consensus. By comprehensive review of recent and valuable literature and expert opinions, the recommendations included indications, pre-procedural evaluations, procedural techniques, post-procedural monitoring, efficacy, and safety, providing a comprehensive review of the application of RFA. The consensus effectively consolidates advice regarding thyroid RFA in clinical practice for local experts.
Keywords: Thyroid; Ultrasound; Radiofrequency ablation; Nodule; Thyroid recurrent cancer; Consensus
TOOLS
PDF Links  PDF Links
METRICS
0
Crossref
63
View
1
Download
We recommend
Editorial Office
A-304 Mapo Trapalace, 53 Mapo-daero, Mapo-gu, Seoul 04158, Korea
TEL : +82-2-763-5627   FAX : +82-2-763-6909   E-mail : office@ultrasound.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Society of Ultrasound in Medicine.                 Developed in M2PI
Close layer
prev next